Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation

Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation

ABO incompatible kidney transplant recipients receive higher dose of immunosuppression. Previous data indicate that the incidence of malignancy is not higher in these patients. Compared to the general population, renal transplant recipients are at 4.4-fold higher risk of developing myeloma. We descr...

Full description

Bibliographic Details
Main Authors: B Kirushnan, B Subbarao, P Prabhu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Indian Journal of Nephrology
Subjects:
ABO incompatible
Epstein-Barr virus
multiple myeloma
posttransplant lymphoproliferative disease
renal transplantation
Online Access:http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2016;volume=26;issue=4;spage=280;epage=283;aulast=Kirushnan

Internet

http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2016;volume=26;issue=4;spage=280;epage=283;aulast=Kirushnan

Similar Items